Raymond James Downgrades AMAG Pharmaceuticals (AMAG) to Underperform
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Raymond James downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Market Perform to Underperform.
For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $35.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Monster Beverage (MNST) to Neutral, 'Cost Pressures and Weaker Low-end Consumer'
- Stifel Downgrades HashiCorp Inc (HCP) to Hold
- Leerink Partners Downgrades CureVac (CVAC) to Market Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
